Spots Global Cancer Trial Database for chop regimen
Every month we try and update this database with for chop regimen cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides | NCT00002557 | Lymphoma | CHOP regimen doxorubicin hyd... etoposide leucovorin calc... methotrexate | - | National Cancer Institute (NCI) | |
| Go-CHOP as the Frontline Therapy for PTCL | NCT05963347 | Peripheral T Ce... | Golidocitinib CHOP Regimen | 18 Years - | Henan Cancer Hospital | |
| Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | NCT00004179 | Lymphoma | rituximab CHOP regimen cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Treatment of Peripheral T-cell Lymphoma | NCT01664975 | Peripheral T-ce... | GDPT regimen CHOP regimen | 14 Years - 70 Years | Zhengzhou University | |
| Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | NCT00003541 | Lymphoma | filgrastim CHOP regimen carboplatin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide prednisone vincristine sul... peripheral bloo... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma | NCT00002565 | Lymphoma | bleomycin sulfa... CHOP regimen cisplatin cyclophosphamid... cytarabine doxorubicin hyd... etoposide idarubicin ifosfamide mesna methylprednisol... mitoxantrone hy... prednisone vincristine sul... | 15 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | NCT00005867 | Lymphoma | bleomycin sulfa... CHOP regimen cyclophosphamid... doxorubicin hyd... etoposide mitoxantrone hy... prednisolone vincristine sul... | 18 Years - 59 Years | National Cancer Institute (NCI) | |
| High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma | NCT00003578 | Lymphoma | CHOP regimen carmustine cyclophosphamid... cytarabine doxorubicin hyd... etoposide melphalan prednisone vincristine sul... autologous bone... peripheral bloo... | 16 Years - 65 Years | National Cancer Institute (NCI) | |
| S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | NCT00003784 | Lymphoma | CHOP regimen cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... tositumomab and... | 18 Years - | SWOG Cancer Research Network | |
| Treatment of Diffuse Large B Cell Lymphoma | NCT01949818 | Diffuse Large B... | Yangzhengxiaoji... CHOP regimen | 14 Years - 70 Years | Zhengzhou University | |
| Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma | NCT00079261 | Lymphoma Small Intestine... | CHOP regimen cyclophosphamid... doxorubicin hyd... gemcitabine hyd... prednisone vincristine sul... | 18 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | NCT00005867 | Lymphoma | bleomycin sulfa... CHOP regimen cyclophosphamid... doxorubicin hyd... etoposide mitoxantrone hy... prednisolone vincristine sul... | 18 Years - 59 Years | National Cancer Institute (NCI) | |
| Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL | NCT00072007 | Leukemia | filgrastim rituximab CHOP regimen cladribine cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... | 18 Years - 65 Years | Swiss Group for Clinical Cancer Research | |
| Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma | NCT00004112 | Lymphoma | rituximab CHOP regimen cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... | 19 Years - 120 Years | University of Nebraska | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma | NCT00003215 | Lymphoma | filgrastim CHOP regimen cyclophosphamid... cytarabine doxorubicin hyd... etoposide leucovorin calc... melphalan methotrexate methylprednisol... mitoxantrone hy... prednisone therapeutic hyd... vincristine sul... bone marrow abl... peripheral bloo... radiation thera... | 18 Years - 60 Years | Swiss Group for Clinical Cancer Research | |
| Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma | NCT00079261 | Lymphoma Small Intestine... | CHOP regimen cyclophosphamid... doxorubicin hyd... gemcitabine hyd... prednisone vincristine sul... | 18 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Treatment of Newly Diagnosed Peripheral T-cell Lymphoma | NCT03631862 | Newly Diagnosed... | Apatinib CHOP Regimen | 14 Years - 70 Years | Zhengzhou University | |
| Treatment of Peripheral T-cell Lymphoma | NCT01664975 | Peripheral T-ce... | GDPT regimen CHOP regimen | 14 Years - 70 Years | Zhengzhou University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
